Neuropsychological Assessment Of The Oldest-Old Population.(NEUROPSIC-GR)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age80+
SponsorConsorci Sanitari de l'Alt Penedès i Garraf
About this trial
Neuropsychological tests currently considered to evaluate the cognitive performance of the oldest-old population (more than 80 years) are not adapted to this group population. This trial aims to determine the normal limits for this group population of a set of 18 neuropsychological test. Results may improve the diagnostic cognitive evaluation of this population.
Eligibility criteria
Qualifiers
80 or more years old
Residence at Comarca del Garraf
Able to be transfered to study center
Sufficient reading and writing capacity to carry out the neuropsychological tests, at the evaluator's discretion.
Disqualifiers
Patient at end-of-life situation or with a very short life expectancy (days-weeks).
Hospital admission in the previous 3 months.
History of relevant mental illness: major depression, psychosis, bipolar disorder, obsessive-compulsive disorder.
Disease of the central nervous system with possible cognitive impairment: Parkinson's disease, multiple sclerosis, brain tumor, stroke with cognitive impairment, epilepsy, severe traumatic brain injury.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
120 Participants
are grouped into 1 trial groupSponsors and collaborators
Consorci Sanitari de l'Alt Penedès i Garraf
Lead sponsor
Centro de Salud Vilanova i la Geltrú 2 Jaume I, Barcelona, Spain
Collaborator
Centro de Salud Vilanova i la Geltrú 3 Baix A Mar, Barcelona, Spain
Collaborator
Centro de Salud Les Roquetes-Sant Pere de Ribes, Barcelona, Spain
Collaborator
Gerència Territorial Metropolitana Sud, Alt Penedès i Garraf, Barcelona, Spain
Collaborator
Centro de Salud Sant Pere de Ribes, Barcelona, Spain
Collaborator
Centro de Salud Vilanova i la Geltrú 1 Sant Joan, Barcelona, Spain
Collaborator
Centro de Salud Sitges, Barcelona, Spain
Collaborator
Source ClinicalTrials.gov